Related Experiment Video
Updated: Feb 12, 2026

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
CD8+ T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy
Jillian Rosenberg1, Jun Huang1,2
1Committee on Cancer Biology, The University of Chicago, IL 60637, USA.
Abstract:
CD8+ T cells and NK cells are both cytotoxic effector cells of the immune system, but the recognition, specificity, sensitivity, and memory mechanisms are drastically different. While many of these topics have been extensively studied in CD8+ T cells, very little is known about NK cells. Current cancer immunotherapies mainly focus on CD8+ T cells, but have many issues of toxicity and efficacy. Given the heterogeneous nature of cancer, personalized cancer immunotherapy that integrates the power of both CD8+ T cells in adaptive immunity and NK cells in innate immunity might be the future direction, along with precision targeting and effective delivery of tumor-specific, memory CD8+ T cells and NK cells.
Related Concept Videos
Complementary DNA
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy
Parallel Processing
Parallel Resonance
Resistors In Parallel

